1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Genome Editing Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Genome Editing Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Genome Editing Market Regional Analysis
6.2 Europe Genome Editing Market Revenue 2019-2028 (US$ Million)
6.3 Europe Genome Editing Market Forecast Analysis
7. Europe Genome Editing Market Analysis – by Technology
7.1 CRISPR
- 7.1.1 Overview
- 7.1.2 CRISPR: Europe Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 TALEN
- 7.2.1 Overview
- 7.2.2 TALEN: Europe Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Antisense
- 7.3.1 Overview
- 7.3.2 Antisense: Europe Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Europe Genome Editing Market Analysis – by Application
8.1 Cell Line Engineering
- 8.1.1 Overview
- 8.1.2 Cell Line Engineering: Europe Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Genetic Engineering
- 8.2.1 Overview
- 8.2.2 Genetic Engineering: Europe Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.3 Diagnostic Applications
- 8.3.1 Overview
- 8.3.2 Diagnostic Applications: Europe Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.4 Drug Discovery
- 8.4.1 Overview
- 8.4.2 Drug Discovery: Europe Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Europe Genome Editing Market Analysis – by End User
9.1 Pharmaceutical and Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Pharmaceutical and Biotechnology Companies: Europe Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Academic and Research Institutes
- 9.2.1 Overview
- 9.2.2 Academic and Research Institutes: Europe Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Clinical Research Organizations
- 9.3.1 Overview
- 9.3.2 Clinical Research Organizations : Europe Genome Editing Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Europe Genome Editing Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Genome Editing Market Breakdown, by Key
Country, 2022 and 2028 (%)
- 10.2.1.1 Europe Genome Editing Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UK:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 UK: Europe Genome Editing Market Breakdown, by Technology
- 10.2.1.1.2 UK: Europe Genome Editing Market Breakdown, by Application
- 10.2.1.1.3 UK: Europe Genome Editing Market Breakdown, by End User
- 10.2.1.2 Germany:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Germany: Europe Genome Editing Market Breakdown, by Technology
- 10.2.1.2.2 Germany: Europe Genome Editing Market Breakdown, by Application
- 10.2.1.2.3 Germany: Europe Genome Editing Market Breakdown, by End User
- 10.2.1.3 France:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 France: Europe Genome Editing Market Breakdown, by Technology
- 10.2.1.3.2 France: Europe Genome Editing Market Breakdown, by Application
- 10.2.1.3.3 France: Europe Genome Editing Market Breakdown, by End User
- 10.2.1.4 Russia:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Russia: Europe Genome Editing Market Breakdown, by Technology
- 10.2.1.4.2 Russia: Europe Genome Editing Market Breakdown, by Application
- 10.2.1.4.3 Russia: Europe Genome Editing Market Breakdown, by End User
- 10.2.1.5 Italy:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Italy: Europe Genome Editing Market Breakdown, by Technology
- 10.2.1.5.2 Italy: Europe Genome Editing Market Breakdown, by Application
- 10.2.1.5.3 Italy: Europe Genome Editing Market Breakdown, by End User
- 10.2.1.6 Rest of Europe:
Europe Genome Editing Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.6.1 Rest of Europe: Europe Genome Editing Market Breakdown, by Technology
- 10.2.1.6.2 Rest of Europe: Europe Genome Editing Market Breakdown, by Application
- 10.2.1.6.3 Rest of Europe: Europe Genome Editing Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 MERCK KGaA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Lonza
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Horizon Discovery Group plc.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Integrated DNA Technologies
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 GenScript
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 New England Biolabs
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Eurofins Scientific
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 CRISPR Therapeutics
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations